IP Library Granted Patent US 9,078,665
Granted Patent B2
US 9,078,665 · App. 13/630,135 · Granted Jul 14, 2015

Multiple treatment zone ablation probe

Inventors: Kevin Moss (Tracy, CA); Robert Pearson (San Jose, CA)
Assignee: AngioDynamics, Inc.
A61B18/1487A61B18/18A61B18/1815A61B2018/00083A61B2018/00273A61B2018/00529A61B2018/00577A61B2018/00589A61B2018/00613A61B2018/1467A61B2018/1475A61B2019/306
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,078,665
App. No.
13/630,135
Granted
Jul 14, 2015
Kind
B2
Abstract

An energy delivery probe and method of using the energy delivery probe to treat a patient is provided herein. The energy delivery probe has at least one probe body having a longitudinal axis and at least a first trocar and a second trocar. Each trocar comprises at least two electrodes that are electrically insulated from each other, and each electrode is independently selectively activatable. An insulative sleeve is positioned in a coaxially surrounding relationship to each of the first trocar and the second trocar. The probe also has a switching means for independently activating at least one electrode. The method involves independently and selectively activating the first and second electrodes to form an ablation zone, then repeating the ablation by delivering energy to a second set of electrodes, producing one or more overlapping ablation zone, and eliminating the need to reposition the ablation probes.

Claims (28)

1. A method of treating a patient, wherein the method comprises:

identifying a target tissue;

providing at least one energy delivery probe comprising

at least a first shaft and a second shaft, wherein each shaft comprises at least a first electrode and a second electrode that are electrically insulated from each other, and wherein each electrode is independently selectively activatable, and

an insulative sleeve positioned in a coaxially surrounding relationship to at least a portion of each of the first shaft and the second shaft,

inserting the probe into or near the target tissue; and

delivering electrical energy between the first electrode on the first shaft and the first electrode on the second shaft to ablate the target tissue, thereby forming a first ablation zone, the first electrodes of the first and second shafts defining a first combination of electrodes;

switching to a second combination of electrodes such that at least one electrode in the second combination is different from the first combination without repositioning the probe;

delivering energy to the switched second combination of electrodes to ablate the target tissue, thereby forming a second ablation zone.

2. The method of claim 1 , wherein the method further comprises simultaneously delivering energy to the first electrode on the first shaft and the first electrode on the second shaft.

3. The method of claim 1 , wherein the method further comprises inserting the probe into or near the target tissue such that the shafts are substantially parallel, and at least one of the electrodes on the first shaft is substantially parallel to at least one of the electrodes on the second shaft.

4. The method of claim 1 , wherein the first ablation zone and the second ablation zone are overlapping.

5. The method of claim 1 , wherein the method further comprises: before delivering energy to the first combination of electrodes, adjusting the position of at least one of the insulative sleeves.

6. The method of claim 1 , wherein the method further comprises: after delivering energy to the first combination of electrodes, adjusting the position of at least one of the insulative sleeves.

7. The method of claim 1 , wherein the method further comprises delivering energy selected from the group comprising: electrical energy, radiofrequency (RF) energy, and microwave energy.

8. The method of claim 7 , wherein the method further comprises delivering electrical energy to the tissue sufficient to cause irreversible electroporation of the target tissue but insufficient to cause thermal damage to the target tissue.

9. The method of claim 7 , wherein the probe further comprises a proximal end, a distal end, and at least one anchor positioned at the distal end of the probe, and wherein after inserting the probe into the target tissue, the anchor is deployed to securely position the probe in relation to the target tissue.

10. A method of treating a patient, wherein the method comprises:

identifying a target tissue;

providing at least one energy delivery probe comprising

at least a first shaft and a second shaft, wherein each shaft comprises at least a first electrode and a second electrode that are electrically insulated from each other, and wherein each electrode is independently selectively activatable, and

an insulative sleeve positioned in a coaxially surrounding relationship to at least a portion of each of the first shaft and the second shaft,

inserting the probe into or near the target tissue;

infusing a fluid through the probe, wherein the fluid is delivered to the target tissue;

delivering electrical energy simultaneously between the first electrode on the first shaft and the first electrode on the second shaft to ablate the target tissue, thereby forming a first ablation zone, the first electrodes of the first and second shafts defining a first combination of electrodes;

switching to a second combination of electrodes such that at least one electrode in the second combination is different from the first combination without repositioning the probe;

delivering energy to the switched second combination of electrodes to ablate the target tissue, thereby forming a second ablation zone.

11. The method of claim 10 , wherein the step of delivering electrical energy simultaneously between the first combination of electrodes to ablate the target tissue, thereby forming a first ablation zone is sufficient to irreversibly electroporate the target tissue.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2022
From: MOSS, KEVIN; ROBERT M. PEARSON
To: ANGIODYNAMICS, INC.
Reel/Frame 060935/0147 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 040688/0540 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
SECURITY AGREEMENT Recorded Sep 30, 2013
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031315/0720 →
Continuity (2)
Provisional Application 61540190 · Sep 28, 2011
Related Publication 20130090646A1 · Apr 11, 2013